JERUSALEM and NEEDHAM, Massachusetts, August 26 /PRNewswire-FirstCall/ -- Oridion Systems Ltd. (SWX: ORIDN) today announced an OEM agreement with Spacelabs Healthcare, a leading global medical device and service company. With this agreement, Spacelabs now employs Oridion Microstream(R) capnography technology in its new, compact and ultra-lightweight patient monitoring system, elance.
Spacelabs Healthcare, recognizing the importance of monitoring CO2, has decided to use the Oridion patented Microstream capnography technology and proprietary EtCO2 sampling technology in its new elance patient monitoring system. Microstream capnography technology and FilterLine(R) breath sampling products improve patient safety by providing the earliest assessment of a patient's ventilatory status. The Spacelabs new elance monitor with Microstream technology is being launched in the current quarter.
Gerry Feldman, President of Oridion Systems Ltd. said: "We are very proud to have entered into this agreement with Spacelabs Healthcare. It demonstrates our ability to further broaden our already existing, strong portfolio of leading global OEM partners. As our partner, Spacelabs will support the Oridion mission to increase patient safety and improve patient outcomes by employing our world-class Microstream CO2 measurement solutions within their systems."
"Spacelabs is very excited to have the advanced Microstream CO2 measurement technology from Oridion integrated into our new patient monitoring system," said Nicholas Ong, Group President, Emerging Markets Organization at Spacelabs Healthcare, Inc.
Oridion Systems Ltd. (http://www.oridion.com ) is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States, Europe, and Israel.
Oridion develops proprietary medical devices and patient interf
|SOURCE Oridion Systems Ltd.|
Copyright©2008 PR Newswire.
All rights reserved